egtazic acid has been researched along with Urinary Bladder Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, M; Hirata, A; Inokuchi, J; Koga, H; Masuda, K; Naito, S; Okumura, K; Tatsugami, K; Tsunoda, T; Yokomizo, A | 1 |
| Kobayashi, Y; Watanabe, N | 1 |
| Kawasaki, H; Kobayashi, Y; Matsushima, K; Oppenheim, JJ; Saido, T; Yamamoto, K | 1 |
3 other study(ies) available for egtazic acid and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Chelating Agents; Cisplatin; Cross-Linking Reagents; Down-Regulation; Drug Resistance, Neoplasm; Egtazic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inositol 1,4,5-Trisphosphate Receptors; Oligonucleotide Array Sequence Analysis; Poly(ADP-ribose) Polymerases; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Urinary Bladder Neoplasms | 2005 |
Selective release of a processed form of interleukin 1 alpha.
Topics: Calcimycin; Calcium; Calpain; Cell Line; Cysteine Proteinase Inhibitors; Egtazic Acid; Gene Expression; Humans; Interleukin-1; L-Lactate Dehydrogenase; Leucine; Methionine; Molecular Weight; Protein Processing, Post-Translational; Sulfur Radioisotopes; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.
Topics: Calcium; Calpain; Cell Line; Egtazic Acid; Humans; Interleukin-1; Ionomycin; Kinetics; Lipopolysaccharides; Methionine; Monocytes; Protein Processing, Post-Translational; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1990 |